Literature DB >> 2637695

Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus.

Y Maaravi1, E Raz, D Gilon, A Rubinow.   

Abstract

A 26 year old woman with systemic lupus erythematosus, including malar rash, photosensitivity, and arthritis, developed a cerebrovascular accident and acute myocardial infarction. High titres to antinuclear factor, anti-DNA antibodies, positive Venereal Disease Research Laboratory (VDRL) test, and anticardiolipin antibodies were found in her serum. A possible association between the presence of anticardiolipin antibodies and the two major thrombotic events is discussed.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2637695      PMCID： PMC1003894          DOI： 10.1136/ard.48.10.853

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  23 in total

1.  Anticardiolipin antibodies and lupus anticoagulant.

Authors:  E N Harris; S Loizou; H Englert; G Derue; J K Chan; A E Gharavi; G R Hughes
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

2.  Acute myocardial infarction associated with systemic lupus erythematosus documented by coronary arteriograms.

Authors:  Y Takatsu; R Hattori; K Sakaguchi; Y Yui; C Kawai
Journal:  Chest       Date:  1985-07       Impact factor: 9.410

3.  The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients.

Authors:  B H Bulkley; W C Roberts
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

4.  Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody.

Authors:  E N Harris; R A Asherson; A E Gharavi; S H Morgan; G Derue; G R Hughes
Journal:  Br J Haematol       Date:  1985-02       Impact factor: 6.998

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

7.  Recurrent ischemic attacks in two young adults with lupus anticoagulant.

Authors:  G Landi; M V Calloni; M Grazia Sabbadini; P Mannuccio Mannucci; L Candelise
Journal:  Stroke       Date:  1983 May-Jun       Impact factor: 7.914

8.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

9.  Crossreactivity of antiphospholipid antibodies.

Authors:  E N Harris; A E Gharavi; S Loizou; G Derue; J K Chan; B M Patel; C G Mackworth-Young; C C Bunn; G R Hughes
Journal:  J Clin Lab Immunol       Date:  1985-01

10.  The relationship of anti-DNA antibody idiotypes and anti-cardiolipin antibodies to disease activity in systemic lupus erythematosus.

Authors:  D A Isenberg; C B Colaco; C Dudeney; A Todd-Pokropek; M L Snaith
Journal:  Medicine (Baltimore)       Date:  1986-01       Impact factor: 1.889
View more
  1 in total

1.  [Oxidatively modified lipoproteins and their antibodies in patients with antiphospholipid syndromeand systemic lupus erythematosus].

Authors:  B Roch; S Kopprasch; J Pietzsch; H-E Schröder
Journal:  Z Rheumatol       Date:  2004-08       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.